Evidence map›Paper›PMID 28988120›Full record

ArticleToxicology2017

Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells.

Zhen Ren, Si Chen, Tao Qing, Jiekun Xuan, Letha Couch, Dianke Yu, Baitang Ning, Leming Shi, Lei Guo

Open access · greenAbstract read
In one paragraph

Article in Toxicology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Mitochondrial dysfunction and apoptosis underlie the hepatotoxicity of perhexiline.Toxicology in vitro : an international journal published in association with BIBRA · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Zhen RenDivision of Biochemical Toxicology, National Center for Toxicological Research/U.S. FDA, Jefferson, AR 72079, USA.
Si ChenDivision of Biochemical Toxicology, National Center for Toxicological Research/U.S. FDA, Jefferson, AR 72079, USA.
Tao QingSchool of Pharmacy and School of Life Sciences, Fudan University, Shanghai 200438, China.
Jiekun XuanDivision of Biochemical Toxicology, National Center for Toxicological Research/U.S. FDA, Jefferson, AR 72079, USA.
Letha CouchDivision of Biochemical Toxicology, National Center for Toxicological Research/U.S. FDA, Jefferson, AR 72079, USA.
Dianke YuDivision of Bioinformatics and Biostatistics, National Center for Toxicological Research/U.S. FDA, Jefferson, AR 72079, USA.
Baitang NingDivision of Systems Biology, National Center for Toxicological Research/U.S. FDA, Jefferson, AR 72079, USA.
Leming ShiSchool of Pharmacy and School of Life Sciences, Fudan University, Shanghai 200438, China.
Lei GuoDivision of Biochemical Toxicology, National Center for Toxicological Research/U.S. FDA, Jefferson, AR 72079, USA. Electronic address: Lei.Guo@fda.hhs.gov.
National Center for Toxicological Research · USUnited States Food and Drug Administration · USFudan University · CN

Funding

Intramural FDA HHS FD999999
6 · The paper itself

Abstract

Leflunomide, used for the treatment of rheumatoid arthritis, has been reported to cause severe liver problems and liver failure; however, the underlying mechanisms are not clear. In this study, we used multiple approaches including genomic analysis to investigate and characterize the possible molecular mechanisms of the cytotoxicity of leflunomide in hepatic cells. We found that leflunomide caused endoplasmic reticulum (ER) stress and activated an unfolded protein response, as evidenced by increased expression of related genes including CHOP and GADD34; and elevated protein levels of typical ER stress markers including CHOP, ATF-4, p-eIF2α, and spliced XBP1. The secretion of Gaussia luciferase was suppressed in cells treated with leflunomide in an ER stress reporter assay. Inhibition of ER stress with an ER stress inhibitor 4-phenylbutyrate, and knockdown of ATF-4 and CHOP genes partially protected cells upon leflunomide exposure. In addition, both genomic and biochemical analyses revealed that JNK and ERK1/2 of MAPK signaling pathways were activated, and both contributed to the leflunomide-induced cytotoxicity. Inhibiting JNK activation using a JNK inhibitor attenuated the ER stress and cytotoxicity of leflunomide, whereas inhibiting ERK1/2 using an ERK1/2 inhibitor or ERK1/2 siRNA increased the adverse effect caused by leflunomide, suggesting opposite roles for the two pathways. In summary, our data indicate that both ER stress and the activation of JNK and ERK1/2 contribute to leflunomide-induced cytotoxicity.

Indexed as

MAP Kinase Signaling SystemSignal TransductionActivating Transcription Factor 4Endoplasmic Reticulum StressHepatocytesHep G2 CellsHumansIsoxazolesLeflunomidePhenylbutyratesSequence Analysis, RNATranscription Factor CHOPUnfolded Protein Response4-phenylbutyric acidActivating Transcription Factor 4ATF4 protein, humanDDIT3 protein, humanIsoxazolesLeflunomidePhenylbutyratesTranscription Factor CHOPER stressGene expressionLeflunomideLiver toxicityMAPK pathwayRNA-seq

Identifiers

PMID28988120
PMCPMC5736314
OpenAlexW2763669115

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.